On Demand Webinars

1. Plasmid DNA Downstream Purification Process 4/11/2023

   Large scale production of plasmid DNA requires an in-depth understanding and optimization of the entire downstream process. Explore a complete solution, from harvest to bulk filtration.

2. Keys To Successful mRNA Manufacturing 4/26/2022

   How PCR-based technology can accelerate mRNA development and manufacturing and design principles/critical parameters to enable the rapid development of lipids for RNA formulation.

3. Analyzing COVID-19 Vaccine Purity Using LC-MS Technologies 11/8/2022

   Explore why process-related impurities are a concern in vaccines and present results and learnings from LC-MS analyses of several mRNA- and protein-based vaccines for COVID-19.

4. Optimize DNA Storage Using Dedicated Fluoropolymer Film 5/9/2023

   Discover how to integrate appropriate materials and tools for oligonucleotide handling, optimize DNA storage using dedicated fluoropolymer film, perform complex biochemical reactions in bags, and more.

5. Validation Of mRNA Concentration Determination 8/20/2023

   mRNA-based therapeutics require comprehensive analytical testing to meet regulatory requirements. Optimize processes and ensure fast and reliable results as you bring your product to market.

6. RNA Interference - From Single Gene Studies To Whole Genome Screens 11/7/2022

   Endoribonuclease-prepared siRNAs (esiRNAs) are able to overcome the limitations of RNAi. Learn about esiRNAs, their advantages over standard siRNAs, and ways this technology is utilized in different research fields.

7. Sustainable Approaches To Oligonucleotide Manufacturing

   An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.

8. Evaluation Criteria Of Freezer Systems For Bulk Pharmaceuticals 11/1/2023

   Review data and evidence that demonstrate the benefits of an integrated approach in achieving critical end-user goals, such as scalability, efficiency, sustainability, and optimizing process economics.

9. Engaging Early In Process Development To Bring mRNA Sequences To Life

   Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.

10. Addressing Industry Challenges In mRNA Product Commercialization

    While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.